Formo

Formo is Europe's most prominent fermentation-made cheese company, and it has done what most alt-dairy startups only promise: get real product onto mainstream retail shelves. Its koji-protein cheese line, sold under names including Frischhain, launched across thousands of supermarket locations — REWE, BILLA, and METRO in Germany and Austria — positioning Formo as a genuine challenger brand rather than a niche health-food curiosity. The technical approach is pragmatic: koji-protein fermentation delivers a shippable, cost-viable product today while the company continues longer-horizon work on precision-fermented dairy milk proteins for future generations of product. That sequencing matters — Formo is generating retail revenue now rather than waiting on the harder, more capital-intensive precision-fermentation milestone. It raised a $61M Series B in September 2024, reported as one of Europe's largest rounds for animal-free cheese, with cumulative financing well above €100M — serious capital for a category most investors have soured on. Europe's cheese market is enormous, culturally central, and increasingly pressured by sustainability regulation and shifting consumer attitudes toward dairy's climate footprint. A brand that has already won shelf space at the continent's biggest grocers, with the capital and technical roadmap to keep improving, is the clearest bet that animal-free cheese can move from novelty to mainstream in Europe.

Cheese is one of the hardest products in food to replicate, and koji-protein alternatives — however cleverly marketed — must clear the exceptionally high bar of European palates that treat cheese as a cultural institution. Winning distribution at REWE, BILLA, and METRO is an achievement, but shelf placement is not sell-through; the graveyard of plant-based dairy is full of products that got listed and then delisted when trial didn't convert to repeat purchase. Formo's more ambitious precision-fermented milk-protein work — the piece that could deliver truly cheese-identical products — remains in development, meaning today's koji line is a bridge product competing against both conventional dairy and a crowded field of vegan cheeses on taste and price, neither of which favors a premium newcomer. The broader plant-based and alt-dairy category is in a well-documented downturn, with declining retail volumes and investor retreat; even €100M+ raised is thin against the scale European retail demands and the marketing spend needed to build a challenger brand across a fragmented, multi-country continent. Regulatory and labeling battles over "cheese" and dairy terms add friction in the EU. Formo is executing better than most, but it is selling a difficult product into a skeptical, downturning category, on capital that must stretch across both a live retail push and an unfinished technology bet.